All In Biotech

Drug Trial Radar · NCT05166109

A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)

A Phase II Pilot Trial of Vamorolone vs. Placebo for the Treatment of Becker Muscular Dystrophy

Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

46

Actual

Start

Jul 7, 2022

Primary completion

Aug 18, 2025

Study completion Aug 18, 2025

Sponsor

Lead sponsor
ReveraGen BioPharma, Inc.Industry
Sponsor type
Industry
Collaborators
Santhera Pharmaceuticals
First posted
Dec 21, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase II pilot study is a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, PK, PD, and exploratory clinical efficacy of vamorolone 500mg (250mg for body weight \<50 kg) daily administered orally compared to placebo over a treatment period of 24 weeks in males with BMD. Funding Source - FDA OOPD

Conditions

  • Becker Muscular Dystrophy

Interventions

  • VamoroloneDrug

    Vamorolone 4.0% wt/wt oral suspension will be administered for the duration of the study.

  • PlaceboDrug

    Placebo to Vamorolone 4.0% wt/wt oral suspension will be administered for the duration of the study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE Version 5.0Time frame: 24 weeks
  2. Total Number of Adverse Events as Assessed by CTCAE Version 5.0Time frame: 24 weeks

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Pittsburgh

    Pittsburgh, Pennsylvania

  • Azienda Ospedale Universita Padova

    Padova, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.